AsraZAhmedMD

Hematology • Ann Arbor, MI

Associate Professor, Internal Medicine, University of Michigan Medical School

Join to view full profile

Dr. Ahmed is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ahmed's full profile

Already have an account?

Office
1500 E Medical Center Dr
Ann Arbor, MI 48109
Phone+1 734-936-4000

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 1996 - 1999
Trinity Health Ann Arbor HospitalResidency, Internal Medicine, 1993 - 1996
The University of Toledo College of MedicineClass of 1993

Certifications & Licensure

MI State Medical License 1998 - 2026
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

Clinical Excellence Society Department of Internal Medicine University of Michigan Medical School, 2019
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Publications & Presentations

PubMed

342 citations
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma
Andrzej Jakubowiak, Dominik Dytfeld, Kent A. Griffith, Daniel Lebovic, David H. Vesole
Blood. 2012-08-30
64 citations
Phase II Trial of Combination Therapy With Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Myeloma
Andrzej Jakubowiak, Tara Kendall, Ammar Al-Zoubi, Yasser Khaled, Shin Mineishi
Journal of Clinical Oncology. 2009-10-20
185 citations
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial.
Asra Ahmed, Samuel A. Merrill, Fares Alsawah, Paula L. Bockenstedt, Erica L. Campagnaro
The Lancet. Haematology. 2019-09-16

Lectures

Ruxolitinib Is Active and Well Tolerated in Adult Patients with Secondary Hemophagocytic Lymphohistiocytosis: Preliminary Results of an Ongoing, Open-Label, Single Cen...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
State Of The Art: Kidney & Pancreas Transplantation
University of Michigan Health System, Midland, Michigan - 9/12/2013